COVID-19 Vaccine

Vaccination Information 

Everyone 6 months and older is eligible and encouraged to get a COVID-19 vaccine. Make sure you stay up to date with primary series doses and boosters. Click the tabs to see CDC's vaccination schedule for your age and situation.

Vaccination Schedule for Most PeopleCOVID19-vaccination-schedule-most-people

This section is for people who are NOT moderately or severely immunocompromised. Scroll below to view the vaccine schedule for people who are moderately or severely immunocompromised.

The image provided is an at-a-glance summary of the current CDC guidance for COVID-19 vaccines for most people that is detailed below.

6 months-4 years

Moderna

  • Total doses: 3
  • Primary series: 2 doses (4-8 weeks between doses)
  • Booster dose: 1 updated (bivalent) Moderna booster 2 or more months after completing the 2-dose primary series

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

Pfizer-BioNTech 

  • Total doses: 3
  • Primary series: 3 doses (3-8 weeks between doses 1 and 2; at least 8 weeks between doses 2 and 3)
    • Doses 1 and 2 use the Pfizer monovalent vaccine.
    • Dose 3 uses the Pfizer updated (bivalent) vaccine. The Pfizer monovalent vaccine is no longer authorized as the 3rd dose.
  •  Booster dose: Not currently authorized

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

5-11 years

Moderna 

  • Total doses: 3
  • Primary series: 2 doses (4-8 weeks between doses) 
  • Booster dose: 1 updated (bivalent) mRNA booster 2 or more months after completing the monovalent 2-dose primary series 

6 Months-5 Years Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

6-11 Years Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

Pfizer-BioNTech 

  • Total doses: 3 or more
  • Primary series: 2 doses (3-8 weeks between doses) 
  • Booster dose: 1 updated (bivalent) mRNA booster 2 or more months after either:
    • Completing the monovalent 2-dose primary series -OR-
    • Previously received monovalent booster dose

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

12 years-Adult

Moderna

  • Total doses: 3 or more
  • Primary series: 2 doses (4-8 weeks between doses) 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
  • Completing the monovalent 2-dose primary series -OR-
  • Previously received monovalent mRNA booster dose  

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

 Pfizer-BioNTech

  • Total doses: 3 or more
  • Primary series: 2 doses (3-8 weeks between doses) 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
  • Completing the monovalent 2-dose primary series -OR-
  • Previously received monovalent mRNA booster dose  

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

 Novavax

  • Total doses: 3
  • Primary series: 2 doses (3-8 weeks between doses) 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after completing the 2-dose primary series  

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

* People ages 18 years and older who completed primary vaccination using any COVID-19 vaccine may receive 1 monovalent Novavax booster dose at least 6 months after completion of the primary series if they:

  • Have not received any previous booster doses -AND-
  • Are unable to receive an mRNA vaccine (i.e., mRNA vaccine contraindicated or not available) -OR-
  • Are unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose

J&J Recipients

Johnson and Johnson (Janssen)

  • Total doses: 2 or more
  • Primary series: 1 dose 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
  • Completing the 1-dose primary series -OR-
  • Previously received monovalent booster dose(s) 

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

* People ages 18 years and older who completed primary vaccination using any COVID-19 vaccine may receive 1 monovalent Novavax booster dose at least 6 months after completion of the primary series if they:

  • Have not received any previous booster doses -AND-
  • Are unable to receive an mRNA vaccine (i.e., mRNA vaccine contraindicated or not available) -OR-
  • Are unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose

  

The Food and Drug Administration (FDA) maintains a list of all approved and authorized COVID-19 vaccines. Talk to your healthcare provider for additional guidance. The COVID-19 Vaccination Schedule for People Who are Moderately or Severely Immunocompromised is provided in the table below. The CDC maintains a current COVID-19 vaccine schedule for most people and people who are moderately or severely immunocompromised. 

 Vaccination Schedule for People who are Moderately or Severely Immunocompromised COVID19-vaccination-schedule-immunocompromised.png

This section is for people who are moderately or severely immunocompromised. The immune response following COVID-19 vaccination may differ in people who are moderately or severely immunocompromised at the time of vaccination. CDC has specific guidance for this population.

The image provided is an at-a-glance summary of the current CDC guidance for COVID-19 vaccines for moderately or severely immunocompromised people that is detailed below.

6 months-4 years

Moderna

  • Total doses: 4
  • Primary series: 3 doses (4 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)
  • Booster dose: 1 updated (bivalent) Moderna booster 2 or more months after completing the 3-dose primary series

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

Pfizer-BioNTech 

  • Total doses: 3
  • Primary series: 3 doses (3 weeks between doses 1 and 2; at least 8 weeks between doses 2 and 3)
    • Doses 1 and 2 use the Pfizer monovalent vaccine.
    • Dose 3 uses the Pfizer updated (bivalent) vaccine. The Pfizer monovalent vaccine is no longer authorized as the 3rd dose.
  • Booster dose: Not currently authorized

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

5-11 years

Moderna

  • Total doses: 4
  • Primary series: 3 doses (4 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)
  • Booster dose: 1 updated (bivalent) mRNA booster 2 or more months after completing the monovalent 3-dose primary series 

6 Months-5 Years Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

6-11 Years Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

Pfizer-BioNTech

  • Total doses: 4 or more
  • Primary series: 3 doses (3 weeks between doses 1 and 2; at least 8 weeks between doses 2 and 3) 
  • Booster dose: 1 updated (bivalent) mRNA booster 2 or more months after either:
    • Completing the monovalent 3-dose primary series -OR-
    • Previously received monovalent booster dose 

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

12 years-Adult

Moderna
  • Total doses: 4 or more
  • Primary series: 3 doses (4 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3)
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
    • Completing the monovalent 3-dose primary series -OR-
    • Previously received monovalent mRNA booster dose(s)  

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

Pfizer-BioNTech

  • Total doses: 4 or more
  • Primary series: 3 doses (3 weeks between doses 1 and 2; at least 4 weeks between doses 2 and 3) 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
  • Completing the monovalent 3-dose primary series -OR-
  • Previously received monovalent mRNA booster dose(s)  

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

Novavax

  • Total doses: 3
  • Primary series: 2 doses (3 weeks between doses) 
  • Booster dose*: 1 updated (bivalent) mRNA booster 2 or more months after completing the 2-dose primary series  

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

* People ages 18 years and older who completed primary vaccination using any COVID-19 vaccine may receive 1 monovalent Novavax booster dose at least 6 months after completion of the primary series if they:

  • Have not received any previous booster doses -AND-
  • Are unable to receive an mRNA vaccine (i.e., mRNA vaccine contraindicated or not available) -OR-
  • Are unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose

J&J Recipients

Johnson and Johnson (Janssen)

  • Total doses: 3 or more
  • Primary series: 1 dose of Johnson & Johnson
  • Additional dose: 1 dose of an mRNA vaccine at least 4 weeks after dose 1 
  • Booster dose*: 1 updated (bivalent) booster 2 or more months after either:
  • Completing the primary series and additional dose -OR-
  • Previously received monovalent booster dose(s) 

Vaccine Fact Sheet: English, Español, አማርኛ, العربية, বাংলা, 한국어, Монгол, Pусский, 中文(简体), ไทย, Tiếng Việt

* People ages 18 years and older who completed primary vaccination using any COVID-19 vaccine may receive 1 monovalent Novavax booster dose at least 6 months after completion of the primary series if they:

  • Have not received any previous booster doses -AND-
  • Are unable to receive an mRNA vaccine (i.e., mRNA vaccine contraindicated or not available) -OR-
  • Are unwilling to receive an mRNA vaccine and would otherwise not receive a booster dose

 

The Food and Drug Administration (FDA) maintains a list of all approved and authorized COVID-19 vaccines. Talk to your healthcare provider for additional guidance. The COVID-19 Vaccination Schedule for Most People (people who are NOT moderately or severely immunocompromised) is provided in the table above. The CDC maintains a current COVID-19 vaccination schedule for most people and people who are moderately or severely immunocompromised. 

Additional Resources (last updated 6/24/2022)

 

Back to top